Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiptor in Interstitial Cystitis/Bladder Pain Syndrome (LEADERSHIP 301)
NCT02858453Phase 3Unknown
- Sponsor
- Aquinox Pharmaceuticals
- Start
- Jul 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of AQX-1125 in interstitial cystitis (IC), bladder pain syndrome (BPS), sponsored by Aquinox Pharmaceuticals. Status: unknown.
02
Drugs
AQX-1125
03
Conditions
interstitial cystitis (IC)bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT02858453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858453.